Fierce Pharma: Reputation A Top Priority When Picking Prescription Meds

Prescription paper and pills | We. Communications

A Pharma company's reputation Ranked As A Leading Factor in Physician Prescription Decisions, According to We.'s Latest Healthy reputation: More Than Medicine Report

Fierce Pharma, Jacqueline Renfrow, 1 March 2023

In “Healthy Reputation: More Than Medicine,” healthcare professionals displayed their desire for pharma to go beyond just functional characteristics of a medication to address the entire health experience. In an interview with Fierce Pharma, Stephanie Marchesi, President, Global Health shared findings from We.'s latest report. 

“As communicators, our instincts and anecdotal feedback have told us that corporate reputation is important. But now we have hard evidence of its impact, both as influencing prescribing decisions among HCPs as well as contributing to the bottom line for biotech and pharma companies,” explained Marchesi.

To learn more, read We.'s latest Brands in Motion Report "Healthy Reputation: More Than Medicine."

 

   Full Article

 

(Photo courtesy of Fierce Pharma - Getty/LIgorko)

Explore more

Stephanie Marchesi expanded role as president emea | We. Communications

We. Communications Announces Stephanie Marchesi's Expanded Role as President, EMEA

Schoen Clinic sign | We. Communications

PRovoke: Private Healthcare Group Appoints WE Communications

Group of communications leaders from We. Communications and Chase Advisors

Earned First: “We Are All Responsible”—AI in Healthcare Roundtable

We. Named a Great Place to Work

Gretchen Ramsey and Kristen Jordan-Poinsette headshots | We. Communications

We. at Fierce Pharma PR & Comms Summit 2024

Colorful arrows pointing at the words PR | We. Communications

Business Live: Will AI Take the 'R' Out of 'PR'?